Tumor genomic alterations appeared to differ among Black, white and Asian men with prostate cancer, according to results of a study published in The New England Journal of Medicine. Brandon A. Mahal, M.D., assistant professor of radiation oncology and assistant director of community outreach and engagement at University of Miami Sylvester Comprehensive Cancer Center, spoke with Healio about this discovery.